TWO SIGMA ADVISERS, LP - REVANCE THERAPEUTICS INC ownership

REVANCE THERAPEUTICS INC's ticker is RVNC and the CUSIP is 761330109. A total of 116 filers reported holding REVANCE THERAPEUTICS INC in Q2 2019. The put-call ratio across all filers is 2.86 and the average weighting 0.6%.

Quarter-by-quarter ownership
TWO SIGMA ADVISERS, LP ownership history of REVANCE THERAPEUTICS INC
ValueSharesWeighting
Q2 2023$28,448,440
-43.0%
1,124,000
-27.5%
0.07%
-44.2%
Q1 2023$49,909,395
+131.9%
1,549,500
+32.9%
0.13%
+115.0%
Q4 2022$21,518,822
+57.0%
1,165,700
+129.7%
0.06%
+50.0%
Q3 2022$13,703,000
+814.8%
507,500
+368.2%
0.04%
+900.0%
Q2 2022$1,498,000
-7.8%
108,400
+67.8%
0.00%
-20.0%
Q3 2020$1,624,000
+8.6%
64,600
+5.6%
0.01%
+25.0%
Q2 2020$1,495,000
+103.7%
61,200
+23.4%
0.00%
+33.3%
Q1 2020$734,000
+241.4%
49,600
+198.8%
0.00%
+200.0%
Q2 2019$215,000
-62.3%
16,600
-54.1%
0.00%0.0%
Q1 2019$571,000
+21.0%
36,200
+90.5%
0.00%0.0%
Q3 2018$472,000
-58.4%
19,000
-54.0%
0.00%
-66.7%
Q2 2018$1,134,000
+65.1%
41,306
+85.2%
0.00%
+50.0%
Q1 2018$687,000
+100.3%
22,300
+132.3%
0.00%
+100.0%
Q4 2017$343,000
+9.6%
9,600
-2.0%
0.00%
-50.0%
Q2 2015$313,000
-43.0%
9,800
-63.0%
0.00%
-50.0%
Q1 2015$549,00026,5000.00%
Other shareholders
REVANCE THERAPEUTICS INC shareholders Q2 2019
NameSharesValueWeighting ↓
NovaQuest Capital Management, L.L.C. 1,558,426$42,779,00061.17%
Essex Woodlands Management, Inc. 3,342,047$91,739,00021.30%
Sio Capital Management, LLC 101,292$2,780,0001.54%
Fosun International Ltd 472,532$12,971,0000.66%
Rhenman & Partners Asset Management AB 203,181$5,577,0000.57%
ArrowMark Colorado Holdings LLC 1,804,275$49,527,0000.46%
ESSEX INVESTMENT MANAGEMENT CO LLC 87,355$2,398,0000.30%
FOX RUN MANAGEMENT, L.L.C. 18,477$507,0000.16%
Phoenix Investment Adviser LLC 2,400$66,0000.12%
Quinn Opportunity Partners LLC 33,100$909,0000.12%
View complete list of REVANCE THERAPEUTICS INC shareholders